Transitional cell carcinoma pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 107: Line 107:


===Grading===
===Grading===
{| style="border: 0px; font-size: 90%; margin: 3px; width: 800px"
|valign=top|
|+
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|'''Grade'''}}
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|'''Description'''}}
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; align=center" |
Grade 1
| style="padding: 5px 5px; background: #F5F5F5;" align=center |
Tumors with the least degree of cellular anaplasia compatible with a diagnosis of malignancy
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; align=center" |
[[CD79a]]
| style="padding: 5px 5px; background: #F5F5F5;" align=center |
''' Positive'''
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; align=center" |
[[CD5]]
| style="padding: 5px 5px; background: #F5F5F5;" align=center |
'''Negative'''
|}





Revision as of 19:10, 11 February 2016

Transitional cell carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Transitional cell carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Cystoscopy and Bladder Biopsy

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Transitional cell carcinoma pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Transitional cell carcinoma pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Transitional cell carcinoma pathophysiology

CDC on Transitional cell carcinoma pathophysiology

Transitional cell carcinoma pathophysiology in the news

Blogs on Transitional cell carcinoma pathophysiology

Directions to Hospitals Treating Transitional cell carcinoma

Risk calculators and risk factors for Transitional cell carcinoma pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Pathophysiology

Gross Pathology

Urothelial carcinomas have two main growth patterns:

  • Papillary urothelial carcinomas:
    • Have slim finger-like projections that grow from the lining of the renal pelvis or ureter into the cavity.
  • Flat urothelial carcinomas:
    • Lay flat in the lining of the renal pelvis and ureter.
    • They grow deeper into the layers of the wall of the renal pelvis or ureter rather than into its cavity.

Microscopic Pathology

Non-invasive urothelial carcinoma

Non-invasive urothelial carcinomas are only in the lining of the renal pelvis or ureter and have not grown deeper into the wall of the renal pelvis or ureter. Types of non-invasive urothelial carcinomas include:

  • Non-invasive flat urothelial carcinoma
  • Non-invasive papillary urothelial carcinoma, high grade
  • non-invasive papillary urothelial carcinoma, low grade
  • Non-invasive papillary urothelial neoplasm of low malignant potential (which means there is only a small chance that it will become invasive cancer)

Invasive urothelial carcinoma

  • Invasive urothelial carcinomas grow from the lining of the renal pelvis or ureter into the deeper layers of the renal pelvis or ureter wall, such as lamina propria and muscularis.
  • Urothelial carcinomas with mixed epithelial features are invasive tumors that have different types of cells mixed with the cancer cells.
  • They occur less often than typical invasive urothelial carcinomas and are generally considered to be more aggressive.
  • These rare urothelial carcinomas include the following:
Subtype Description

Urothelial carcinomas with squamous differentiation

  • Have urothelial and squamous cells
  • Observed in 44% of renal pelvis tumors

Urothelial carcinomas with glandular differentiation

  • Have gland cells, and there are spaces between the gland cells

Micropapillary urothelial carcinomas

  • Have micropapillae
  • High grade neoplasm

Sarcomatoid urothelial carcinomas

  • Have cells that look like sarcoma
  • This aggressive carcinoma has often spread to lymph nodes and organs other than the renal pelvis or ureter when it is diagnosed

Nested variant of urothelial carcinomas

  • Have nests, which are groups of anaplastic cells with large nuclei
  • Very rare but aggressive

Microcystic urothelial carcinomas

  • Have cysts in them that can range in size from microscopic to 2 mm
  • Very rare

Lymphoepithelioma-like urothelial carcinomas

  • Have lymphatic tissue mixed with urothelial cells, or transitional cells
  • Very rare carcinoma
  • More common in men than women

Plasmacytoid and lymphoma-like urothelial carcinomas

  • Have tumor cells that look like lymphoma or plasmacytoma

Giant cell urothelial carcinomas

  • Have abnormally large cells with more than one nucleus.

Clear cell urothelial carcinomas

  • Have clear cells (cells with clear cytoplasm and a large nucleus).

Lipid cell variant of urothelial carcinomas

  • Have cells that are filled with fat

Undifferentiated variant of urothelial carcinomas

  • Have cells that don’t have any clear features and don’t look like any other type of cell (they are undifferentiated).

Urothelial carcinomas with trophoblastic differentiation

  • Have cells that look like trophoblasts
  • Trophoblast cells form the tissue that becomes the placenta and the membranes that surround the embryo.

Grading

Grade Description

Grade 1

Tumors with the least degree of cellular anaplasia compatible with a diagnosis of malignancy

CD79a

Positive

CD5

Negative


References

Template:WH Template:WS